Ashley Ringrose

Stable Suppression of a Novel Oncogene, AHI-1, in Human Cutaneous T-Cell Leukemia Cells Normalizes Its Transforming Activity In Vitro and In Vivo and Aberrant Expression of AHI-1 Is Also Present in Leukemic Sezary Cells from Patients with Sezary Syndrome.

Ashley Ringrose, Youwen Zhou, Emily M. Pang et al. · Blood · 2005 · 188 citations

AHI-1 interacts with BCR-ABL and modulates BCR-ABL transforming activity and imatinib response of CML stem/progenitor cells

Liang Zhou, Yun Zhao, Ashley Ringrose et al. · The Journal of Experimental Medicine · 2008 · 72 citations · Full text

Targeting Primitive Chronic Myeloid Leukemia Cells by Effective Inhibition of a New AHI-1–BCR-ABL–JAK2 Complex

Min Chen, Paolo Gallipoli, Donna DeGeer et al. · JNCI Journal of the National Cancer Institute · 2013 · 72 citations · Full text

Properties of CD34+ CML stem/progenitor cells that correlate with different clinical responses to imatinib mesylate

Xiaoyan Jiang, Donna L. Forrest, Franck E. Nicolini et al. · Blood · 2010 · 61 citations · Full text

Identification of tyrosine kinase, HCK, and tumor suppressor, BIN1, as potential mediators of AHI-1 oncogene in primary and transformed CTCL cells

Erin Kennah, Ashley Ringrose, Liang Zhou et al. · Blood · 2009 · 37 citations · Full text